Pulldown assays using tumor tissue showed that the various p53 mutants in our panel interacted with EGFR, with TAD mutants demonstrating an increased association with cytosolic EGFR (Supplementary Fig. 9D). The gene discussed is EGFR; the disease is neoplasm.